Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Virology

• Publication date

  2008-11-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02036-08PMID 18987148PMCID PMC2612355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates.

  2008cited by this paper
• Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

  2008cited by this paper
• High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI.

  2008cited by this paper
• Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C

  2008cited by this paper
• Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection

  2007cited by this paper
• Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

  2007influential reference
• Role of V1V2 and Other Human Immunodeficiency Virus Type 1 Envelope Domains in Resistance to Autologous Neutralization during Clade C Infection

  2007cited by this paper
• HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry

  2007cited by this paper
• Prospects of HIV Env modification as an approach to HIV vaccine design.

  2007cited by this paper
• Broad HIV-1 neutralization mediated by CD4-binding site antibodies

  2007influential reference
• Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope

  2007cited by this paper
• Antibody Responses Elicited in Macaques Immunized with Human Immunodeficiency Virus Type 1 (HIV-1) SF162-Derived gp140 Envelope Immunogens: Comparison with Those Elicited during Homologous Simian/Human Immunodeficiency Virus SHIVSF162P4 and Heterologous HIV-1 Infection

  2006cited by this paper
• The V1, V2, and V3 Regions of the Human Immunodeficiency Virus Type 1 Envelope Differentially Affect the Viral Phenotype in an Isolate-Dependent Manner

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

  2005cited by this paper
• Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles

  2005cited by this paper
• Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

  2005cited by this paper
• Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

  2004influential reference
• Correlation between env V1/V2 Region Diversification and Neutralizing Antibodies during Primary Infection by Simian Immunodeficiency Virus sm in Rhesus Macaques

  2004cited by this paper
• Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1

  2004cited by this paper
• N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies

  2004cited by this paper
• Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.

  2004cited by this paper
• Rapid evolution of the neutralizing antibody response to HIV type 1 infection

  2003cited by this paper
• Nonneutralizing Antibodies to the CD4-Binding Site on the gp120 Subunit of Human Immunodeficiency Virus Type 1 Do Not Interfere with the Activity of a Neutralizing Antibody against the Same Site

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120

  2003cited by this paper
• A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

  2001cited by this paper
• CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization

  1998cited by this paper
• Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes

  1996cited by this paper
• Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

  1996cited by this paper
• Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement

  1996cited by this paper
• Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates

  1995cited by this paper
• Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

  1995cited by this paper
• Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1

  1994cited by this paper
• Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization

  1994influential reference
• Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans

  1993cited by this paper
• Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability

  1993cited by this paper
• Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

  1993influential reference
• Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

  1991cited by this paper
• Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.

  1988cited by this paper
• Identification and Characterization of a New Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody

  year unknowncited by this paper

• mGem: Opening Env and harnessing NK cell effector functions to eliminate HIV-1-infected cells

  2026cites this paper
• Decreased CD4+ T Cell Counts Drive Aberrant B Cell Repertoire Alterations in People Living with HIV.

  2025cites this paper
• Machine learning framework to extract physicochemical features of B-cell epitopes recognized by a cross-reactive antibody

  2025cites this paper
• Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection

  2025cites this paper
• Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development

  2025cites this paper
• Advancing the course of HIV genomics research in Africa

  2025cites this paper
• A machine learning framework to identify complex physicochemical features of B cell epitopes

  2025cites this paper
• HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralizing antibodies

  2024cites this paper
• Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119

  2024cites this paper
• Conformations of membrane human immunodeficiency virus (HIV-1) envelope glycoproteins solubilized in Amphipol A18 lipid-nanodiscs

  2024cites this paper
• Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs

  2024cites this paper
• Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation

  2024cites this paper
• Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1

  2024cites this paper
• A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope

  2024influential citation
• Assessing the impact of autologous neutralizing antibodies on rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaques

  2024cites this paper
• Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis

  2024cites this paper
• Identification of a mimotope of a complex gp41 human immunodeficiency virus epitope related to a non-structural protein of Hepacivirus previously implicated in Kawasaki disease

  2024influential citation
• Priming antibody responses to the fusion peptide in rhesus macaques

  2024cites this paper
• Mass transfer characteristics in disposable rocking bioreactors: A critical review and quantitative data catalogue

  2024cites this paper
• Propagation of non-adherent HL-60 cells in batch cultures maintained in staticand wave-type agitated systems

  2023cites this paper
• Dynamics and durability of HIV-1 neutralization are determined by viral replication

  2023cites this paper
• Conformations of Human Immunodeficiency Virus Envelope Glycoproteins in Detergents and Styrene-Maleic Acid Lipid Particles

  2023cites this paper
• Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor

  2023cites this paper
• HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralization by antibodies

  2023cites this paper
• Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells

  2023cites this paper
• Mapping the interplay between NK cells and HIV: therapeutic implications

  2023cites this paper
• Focusing antibody responses to the fusion peptide in rhesus macaques

  2023cites this paper
• Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles

  2023cites this paper
• ‘Immunization during ART and ATI for HIV-1 vaccine discovery/development’

  2023cites this paper
• Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1

  2023cites this paper
• Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation

  2023cites this paper
• Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies

  2023cites this paper
• Next-generation bNAbs for HIV-1 cure strategies.

  2023cites this paper
• Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens

  2022cites this paper
• Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles

  2022cites this paper
• Coimmunization with Preerythrocytic Antigens alongside Circumsporozoite Protein Can Enhance Sterile Protection against Plasmodium Sporozoite Infection

  2022cites this paper
• An exploration of how broadly neutralizing antibodies might induce HIV remission: the ‘vaccinal’ effect

  2022cites this paper
• Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein

  2022cites this paper
• Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?

  2022cites this paper
• Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities

  2022cites this paper
• Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals

  2022cites this paper
• Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses

  2022cites this paper
• The HIV Env Glycoprotein Conformational States on Cells and Viruses

  2022cites this paper
• HIV-1 infections with multiple founders associate with the development of neutralization breadth

  2022cites this paper
• Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies

  2022cites this paper
• Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond

  2021cites this paper
• Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation

  2021cites this paper
• How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika

  2021cites this paper
• Distinct antibody profiles in HLA-B∗57+, HLA-B∗57− HIV controllers and chronic progressors

  2021cites this paper
• Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination

  2021cites this paper
• Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies

  2021cites this paper
• Polyfunctional Tier 2–Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor

  2021cites this paper
• B Cell Response to Vaccination

  2021influential citation
• Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression

  2021cites this paper
• Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity

  2021cites this paper
• Cross-Neutralizing CRF01_AE-Infected Plasma from Malaysia Targets CD4-Binding Site of Human Immunodeficiency Virus Type-1 Envelope Glycoprotein

  2021cites this paper
• Broadly Neutralizing Antibodies for HIV-1 Prevention

  2021cites this paper
• Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer

  2021cites this paper
• Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

  2021cites this paper
• SIV infection duration largely determines broadening of neutralizing antibody response in macaques.

  2020cites this paper
• A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch

  2020cites this paper
• Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview

  2020cites this paper
• Predicting Antibody Neutralization Efficacy in Hypermutated Epitopes Using Monte Carlo Simulations

  2020cites this paper
• Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions

  2020cites this paper
• Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth

  2020cites this paper
• The Conformational States of the HIV-1 Envelope Glycoproteins.

  2020cites this paper
• Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates

  2020cites this paper
• Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection.

  2020cites this paper
• Targeting the N332-supersite of the HIV-1 envelope for vaccine design

  2020cites this paper
• Immunological approaches to HIV cure.

  2020cites this paper
• Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain

  2020cites this paper
• Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus

  2019cites this paper
• Relative Binding Affinity Prediction of Charge-Changing Sequence Mutations with FEP in Protein–Protein Interfaces

  2019cites this paper
• Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens

  2019cites this paper
• Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1

  2019cites this paper
• HIV Co-Receptor Usage, Broadly Neutralising Antibodies, and Treatment

  2019cites this paper
• Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity

  2019cites this paper
• Higher genetic diversity and viral evolution on key regions of envelope gene are associated with broader neutralizing antibody responses: report of two chronic HIV infected cases.

  2019cites this paper
• Generation of porcine monoclonal antibodies based on single cell technologies.

  2019cites this paper
• Correlates of broadly neutralizing antibody development.

  2019cites this paper
• Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity

  2019cites this paper
• Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users

  2019cites this paper
• Mapping of Neutralizing Antibody Epitopes on the Envelope of Viruses Obtained from Plasma Samples Exhibiting Broad Cross-Clade Neutralization Potential Against HIV-1

  2019cites this paper
• Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope

  2019cites this paper
• Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le A 2-4-Amino Acid Delet ion in the V 5 Region of HIV-1 Env gp 120 Confers Viral Resistance to the Broadly Neutralizing Human Monoclonal Ant ibody , VRC 01 著者

  2019cites this paper
• Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design.

  2019cites this paper
• Novel Vaccine Immunogens from Rare HIV-1 Controllers that Possess Broadly Neutralizing Antibodies

  2019cites this paper
• Broadly neutralizing antibodies and vaccine design against HIV-1 infection

  2019cites this paper
• HIV-1 phylogenetics and vaccines

  2019cites this paper
• Definition of immunoglobulin germline genes by next generation sequencing for studies of antigen-specific b cell responses

  2019cites this paper
• The genetic interaction between HIV and the antibody repertoire

  2019cites this paper
• Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period

  2019cites this paper
• A role for antibodies in natural HIV control.

  2019cites this paper
• The Antibodiome—Mapping the Humoral Immune Response to HIV

  2019cites this paper
• Refining the HIV-1 glycan shield model: dynamics of a heterogeneous envelope trimer and empirical prediction of glycan processing

  2019cites this paper
• Structural Insights from HIV-Antibody Coevolution and Related Immunization Studies

  2018cites this paper
• HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes

  2018cites this paper
• HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

  2018cites this paper
• Immune Interventions to Eliminate the HIV Reservoir.

  2018cites this paper